When insurers require that patients "fail first" before accessing their prescribed treatment, patients can suffer.

When prior authorization delays treatment, patients can see their symptoms worsen and their relationship with their physician erode.

The health care system has focused on disease long enough. It’s time to focus on patients.

In a first-of-its-kind study, the Alliance for Patient Access reveals that non-medical switching can levy widespread damage on patients’ quality of life.

Adam Friedman, MD, discusses access to eczema treatment with the National Eczema Association.

It’s a familiar scenario for most of us. You get sick and go to the doctor. Your doctor takes your medical history, examines you, and makes recommendations about your treatment. Your doctor writes you a prescription. But, for many patients, the process of getting the medication prescribed by their doctor may be far more complicated.

Co-pay accumulator adjustment programs mean big setbacks for patients with serious diseases.

What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access.

Courtney Clayton, MA, shares helpful tops for ensuring successful access to dermatology treatment.

Preventing Discrimination and Offering Quality Benefits for Employees with Dermatological Conditions

Choosing insurance policies that will allow dermatology patients to access appropriate treatment is critical.